Product Description: Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Montepaone M, et al. Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis. Open Access Rheumatol. 2014 Feb 20;6:7-13./[2]Schoch A, et al. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc Natl Acad Sci U S A. 2015 May 12;112(19):5997-6002.